Employees: 201-500
Founded date: 1994
Investors 1
| Date | Name | Website |
| - | Redmont Ca... | redmontcap... |
Mentions in press and media 6
| Date | Title | Description |
| 13.01.2011 | Atherotech Acquired by Behrman Capital | Atherotech, a Birmingham, Alabama-based provider of cardiometabolic testing services that offers the VAP (Vertical Auto Profile) advanced lipid profile test, has been acquired by private equity investment firm Behrman Capital. The equity ca... |
| 04.10.2010 | Industry Ventures raising $300 million fund | Promoted Telemedicine’s potential to provide healthcare to the world’s most vulnerable Teladoc Health Head of R&D Yulun Wang highlights the impact of virtual care in underserved populations around the globe through the World Telehealth ... |
| 18.03.2010 | Cardiac biomarker gets second life | By Mary Vanac Jake Orville always thought the cardiac inflammation biomarker developed by Dr. Stanley Hazen and his colleagues at the Cleveland Clinic was a valuable and proven technology. But his efforts to make it a commercial success for... |
| 17.03.2010 | Cleveland HeartLab: How to go to market with diagnostic test? | Based on Hazen’s research, Cleveland Clinic spin-off company PrognostiX had commercialized a test for myeloperoxidase–an enzyme that indicates inflammation in the artery walls of the heart, which can predict fatal heart attacks or strokes. ... |
| - | Cleveland HeartLab: How to go to market with diagnostic test? | Updated 4:29 p.m., March 18, 2010 The cardiac inflammation biomarker developed by Dr. Stanley Hazen and his colleagues at the Cleveland Clinic was a valuable and proven technology, thought Jake Orville, president and chief executive of Clev... |
| - | Industry Ventures raising $300 million fund | Industry Ventures, which invests in other venture and angel funds but has also made direct investments in healthcare, is raising a sixth fund after drawing down more than half of its 2-year-old, $265 million fund, according to VentureWire. ... |